---
title: "The Nasdaq Biotechnology Index closed up nearly 1.5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259121207.md"
description: "Component stock Applied Therapeutics rose 119.56%, Crinetics Pharma increased by 27.92%, and Annexon rose 20.79% to rank third. Kyverna Therapeutics fell 3.94% to rank third from the bottom, Ardelyx dropped 6.88%, and PepGen declined 13.94%"
datetime: "2025-09-26T20:31:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259121207.md)
  - [en](https://longbridge.com/en/news/259121207.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259121207.md)
generator: "portal-rs"
---

# The Nasdaq Biotechnology Index closed up nearly 1.5%

Component stock Applied Therapeutics rose by 119.56%, Crinetics Pharma increased by 27.92%, and Annexon rose by 20.79%, ranking third.

Kyverna Therapeutics fell by 3.94%, ranking third from the bottom, Ardelyx dropped by 6.88%, and PepGen declined by 13.94%

### Related Stocks

- [ANNX.US](https://longbridge.com/en/quote/ANNX.US.md)
- [PEPG.US](https://longbridge.com/en/quote/PEPG.US.md)
- [APLT.US](https://longbridge.com/en/quote/APLT.US.md)
- [ARDX.US](https://longbridge.com/en/quote/ARDX.US.md)

## Related News & Research

- [‘Open Your Eyes,’ Says Top Investor About Oracle Stock](https://longbridge.com/en/news/301160283.md)
- [Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.](https://longbridge.com/en/news/301114413.md)
- [Palantir vs. Oracle – Why Daniel Ives Says Buy One, Hold the Other](https://longbridge.com/en/news/301155464.md)
- [Broadcom's AI Revenue Is Growing at 221%. Here's Why Custom Chips Could Be a Bigger Business Than GPUs.](https://longbridge.com/en/news/301141333.md)
- [LIVE MARKETS-TSMC earnings could cause another round of consensus upgrades](https://longbridge.com/en/news/301145455.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**